Literature DB >> 12847210

Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection.

Mark J Smyth1, Shayna E A Street, Joseph A Trapani.   

Abstract

Controversy still exists regarding the biological function of granzyme serine proteases released with perforin from the cytotoxic granules of NK cells and CTLs. In particular, it is not clear whether the major granzymes, A and B, play an essential role in tumor rejection mediated by the perforin pathway. We have now examined the relative importance of perforin and granzyme A and B clusters in five different tumor models that stringently distinguish their importance. We conclude that granzyme A and B clusters are not essential for CTL- and NK cell-mediated rejection of spontaneous and experimental tumors, raising the likelihood that either perforin alone or in combination with an additional granzyme or granule component(s) mediates cytotoxicity of tumor cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847210     DOI: 10.4049/jimmunol.171.2.515

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  A quarter century of granzymes.

Authors:  C L Ewen; K P Kane; R C Bleackley
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

Review 2.  Use of protease proteomics to discover granzyme B substrates.

Authors:  Andrew J Bredemeyer; R Reid Townsend; Timothy J Ley
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

Review 4.  The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.

Authors:  Morgan E Wallace; Mark J Smyth
Journal:  Springer Semin Immunopathol       Date:  2005-02-24

Review 5.  Granzyme M: behind enemy lines.

Authors:  S A H de Poot; N Bovenschen
Journal:  Cell Death Differ       Date:  2014-01-10       Impact factor: 15.828

6.  Ex-vivo analysis of CD8+ T cells infiltrating colorectal tumors identifies a major effector-memory subset with low perforin content.

Authors:  Sheng-Wei Ye; Yu Wang; Danila Valmori; Maha Ayyoub; Yan Han; Xiao-Lan Xu; Ai-Lian Zhao; Li Qu; Sacha Gnjatic; Gerd Ritter; Lloyd J Old; Jin Gu
Journal:  J Clin Immunol       Date:  2006-09-12       Impact factor: 8.317

7.  Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection.

Authors:  Miriam Rode; Sandra Balkow; Vera Sobek; Reina Brehm; Praxedis Martin; Astrid Kersten; Tilman Dumrese; Thomas Stehle; Arno Müllbacher; Reinhard Wallich; Markus M Simon
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.

Authors:  Thomas D Cunningham; Xinguo Jiang; David J Shapiro
Journal:  Cell Immunol       Date:  2007-05-08       Impact factor: 4.868

9.  Antigen-specific primed cytotoxic T cells eliminate tumour cells in vivo and prevent tumour development, regardless of the presence of anti-apoptotic mutations conferring drug resistance.

Authors:  Paula Jaime-Sánchez; Elena Catalán; Iratxe Uranga-Murillo; Nacho Aguiló; Llipsy Santiago; Pilar M Lanuza; Diego de Miguel; Maykel A Arias; Julián Pardo
Journal:  Cell Death Differ       Date:  2018-05-09       Impact factor: 15.828

10.  The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.

Authors:  Pratip K Chattopadhyay; Michael R Betts; David A Price; Emma Gostick; Helen Horton; Mario Roederer; Stephen C De Rosa
Journal:  J Leukoc Biol       Date:  2008-10-10       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.